Last updated on November 2017

Fibromyalgia


Brief description of study

Fibromyalgia

Detailed Study Description

A Phase 2a Randomized, Double-Blind, Placebo-controlled, Parallel-group Study to Assess the Analgesic Effects and Safety of ASP0819 in Patients with Fibromyalgia

Clinical Study Identifier: TX883

Contact Investigators or Research Sites near you

Start Over

Katey

Apex Research Institute
Santa Ana, CA USA

Cathy Mancini

Palm Beach Research Center
West Palm Beach, FL USA

Novex Clinical Research, LLC

Novex Clinical Research, LLC
New Bedford, MA USA

Wake Research Associates

Wake Research Associates
Raleigh, NC USA

ClinSearch, LLC

ClinSearch, LLC
Chattanooga, TN USA

BTC of New Bedford, LLC

BTC of New Bedford, LLC
New Bedford, MA USA

Carrie Covert

MediSphere Medical Research Center, LLC
Evansville, IN USA

Greta BonDurant

Central Kentucky Research Associates
Lexington, KY USA